Kim A. Tønseth, MD, PhD,*†‡Charles Filip, MD, PhD,*†Robert Hermann, MD,*Harald Vindenes, MD,* and Hans Erik Høgevold, MD, PhD*†
The patient was born abroad after a normal pregnancy. Immediately after delivery, a very large voluminous GCMN of the back covering about 16% of the total body surface area and additional multiple smaller nevi on the body were demonstrated. The patient and his family immigrated to Norway, and he was referred to our hospital when he was 1.5 years old (Fig.1). His main complaints were severe itching and difficulty in normal everyday activities and sleeping due to the large tumor.
Based on the patient’s complaints, we decided to perform a two-stage operation with (1) excision of the large tumor (Fig.2) and coverage with Integra (Fig.3) and (2) 3 weeks later split-thickness skin transplantation of the 100% vascularized Integra. The split-thickness skin transplantation was harvested with 0.008-inch thickness, meshed 1:1.5, and fixed with vacuum-assisted closure technique at 80 mm Hg (Smith & Nephew, Hull, United Kingdom). Due to multiple smaller nevi on the rest of the body, the split-thickness skin transplant was harvested including these lesions. After additional 5 days, the bandage was removed and 90% of the split-thickness skin transplant had healed. A secondary split-thickness skin transplantation procedure was performed, and 2 months after the primary operation the defect was completely healed (Fig.4).
From the *Department of Plastic and Reconstructive Surgery, Oslo University Hospital, Oslo, Norway; †Institute for Surgical Research, Oslo University Hospital, Oslo, Norway; and ‡Faculty of Medicine, University of Oslo, Oslo, Norway.Corresponding author.Kim A. Tønseth, MD, PhD, Department of Plastic and Reconstructive Surgery, Oslo University Hospital, Postboks 4950 Nydalen, 0424 Oslo, Norway, E-mail: on.fh-suo@htesnotk
Copyright © 2015 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of The American Society of Plastic Surgeons. All rights reserved.This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially.
- Viana AC, Gontijo B, Bittencourt FV. Giant congenital melanocytic nevus. An Bras Dermatol. 2013;88:863–878. [PMC free article] [PubMed] [Google Scholar]
- Arneja J, Gosain A. Giant congenital melanocytic nevi. Plast Reconstr Surg. 2009;124:1e–13e. [PubMed] [Google Scholar]
- Ceballos PI, Ruiz-Maldonado R, Mihm MC., Jr Melanoma in children. N Engl J Med. 1995;332:656–662. [PubMed] [Google Scholar]
- Ka VS, Dusza SW, Halpern AC, et al. The association between large congenital melanocytic naevi and cutaneous melanoma: preliminary findings from an Internet-based registry of 379 patients. Melanoma Res. 2005;15:61–67. [PubMed] [Google Scholar]
- Ruiz-Maldonado R, Tamayo L, Laterza AM, et al. Giant pigmented nevi: clinical, histopathologic, and therapeutic considerations. J Pediatr. 1992;120:906–911. [PubMed] [Google Scholar]
- Leshem D, Gur E, Meilik B, et al. Treatment of congenital facial nevi. J Craniofac Surg. 2005;16:897–903. [PubMed] [Google Scholar]
- Schiestl C, Stiefel D, Meuli M. Giant naevus, giant excision, eleg(i)ant closure? Reconstructive surgery with Integra Artificial Skin to treat giant congenital melanocytic naevi in children. J Plast Reconstr Aesthet Surg. 2010;63:610–615. [PubMed] [Google Scholar]
- Kinsler V, Bulstrode N. The role of surgery in the management of congenital melanocytic naevi in children: a perspective from Great Ormond Street Hospital. J Plast Reconstr Aesthet Surg. 2009;62:595–601. [PubMed] [Google Scholar]